These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6616077)
21. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients. Crowe JP; Hubay CA; Pearson OH; Marshall JS; Rosenblatt J; Mansour EG; Hermann RE; Jones JC; Flynn WJ; McGuire WL Breast Cancer Res Treat; 1982; 2(2):171-6. PubMed ID: 7171837 [TBL] [Abstract][Full Text] [Related]
22. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. Roubidoux MA; Bailey JE; Wray LA; Helvie MA Radiology; 2004 Jan; 230(1):42-8. PubMed ID: 14695385 [TBL] [Abstract][Full Text] [Related]
23. Mammography and morphobiologic characteristics of human breast cancer. Paradiso A; Mangia A; Barletta A; Marzullo F; Ventrella V; Racanelli A; Schittulli F; De Lena M Tumori; 1993 Dec; 79(6):422-6. PubMed ID: 8171744 [TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer. Silfverswärd C; Gustafsson JA; Gustafsson SA; Humla S; Nordenskjöld B; Wallgren A; Wrange O Cancer; 1980 Apr; 45(8):2001-5. PubMed ID: 6245787 [TBL] [Abstract][Full Text] [Related]
25. The influence of obesity and age at diagnosis on the estrogen receptor status of breast cancers. Perimenopausal predominance of estrogen receptor negative tumors. Daniell HW Cancer; 1988 Mar; 61(6):1237-40. PubMed ID: 3342379 [TBL] [Abstract][Full Text] [Related]
26. [Mammographic and pathological features of triple-negative breast cancer]. Wen SY; Han YW; Ma XM; Zhang J; Cui WJ; Cao XC; Wang X Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):291-5. PubMed ID: 22781043 [TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor level and other factors in early recurrence of breast cancer. Westerberg H; Gustafson SA; Nordenskjöld B; Silfverswärd C; Wallgren A Int J Cancer; 1980 Oct; 26(4):429-33. PubMed ID: 7251221 [TBL] [Abstract][Full Text] [Related]
28. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women. Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390 [TBL] [Abstract][Full Text] [Related]
29. Estrogen receptor heterogeneity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer. Straus MJ; Moran R; Muller RE; Wotiz HH Oncology; 1982; 39(4):197-200. PubMed ID: 7088469 [TBL] [Abstract][Full Text] [Related]
30. Mammographic density in relation to tumor biomarkers, molecular subtypes, and mode of detection in breast cancer. Sartor H; Zackrisson S; Elebro K; Hartman L; Borgquist S Cancer Causes Control; 2015 Jun; 26(6):931-9. PubMed ID: 25860114 [TBL] [Abstract][Full Text] [Related]
31. Is there a correlation between breast cancer molecular subtype using receptors as surrogates and mammographic appearance? Killelea BK; Chagpar AB; Bishop J; Horowitz NR; Christy C; Tsangaris T; Raghu M; Lannin DR Ann Surg Oncol; 2013 Oct; 20(10):3247-53. PubMed ID: 23975299 [TBL] [Abstract][Full Text] [Related]
32. Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer. Bertuzzi A; Daidone MG; Di Fronzo G; Silvestrini R Breast Cancer Res Treat; 1981; 1(3):253-62. PubMed ID: 7348575 [TBL] [Abstract][Full Text] [Related]
33. Age-related differences in patients with nonpalpable breast carcinomas. Wazer DE; Gage I; Homer MJ; Krosnick SH; Schmid C Cancer; 1996 Oct; 78(7):1432-7. PubMed ID: 8839548 [TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group. Kinne DW; Butler JA; Kimmel M; Flehinger BJ; Menendez-Botet C; Schwartz M Arch Surg; 1987 Nov; 122(11):1303-6. PubMed ID: 3675194 [TBL] [Abstract][Full Text] [Related]
35. Age as a confounding factor in the association of mammographic dysplasia and estrogen receptor concentration in breast cancer. Boyd NF; Fishell E; Tonkin K; Mobbs BG Breast Cancer Res Treat; 1987 Oct; 10(1):51-4. PubMed ID: 3689983 [TBL] [Abstract][Full Text] [Related]
36. [Factors affecting estrogen and progesterone receptors in primary breast cancer]. Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431 [TBL] [Abstract][Full Text] [Related]
37. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms. Bae MS; Han W; Koo HR; Cho N; Chang JM; Yi A; Park IA; Noh DY; Choi WS; Moon WK Cancer Sci; 2011 Oct; 102(10):1862-7. PubMed ID: 21752153 [TBL] [Abstract][Full Text] [Related]
38. Obesity, estrogen production, and tumor estrogen receptors in women with carcinoma of the breast. Donegan WL; Johnstone MF; Biedrzycki L Am J Clin Oncol; 1983 Feb; 6(1):19-24. PubMed ID: 6837504 [TBL] [Abstract][Full Text] [Related]
39. Non-palpable invasive breast carcinomas from the Stockholm screening project. von Rosen A; Frisell J; Glas U; Hellström L; Nilsson R; Skoog L; Auer G Acta Oncol; 1989; 28(1):23-7. PubMed ID: 2706131 [TBL] [Abstract][Full Text] [Related]
40. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]